Lishui, China Clinical Trials

A listing of Lishui, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 8 clinical trials
Lifestyle Intervention for Patients With Impaired Glucose Regulation

Impaired glucose regulation (IGR) is closely related to overweight/obesity. By studying different dietary patterns (energy-limited diet vs. low-carbohydrate diet) and intensive lifestyle interventions combined with blood glucose monitoring, glucose regulation of overweight/obesity is affected. To improve the blood glucose and related metabolic indexes of patients with impaired (IGR), establish 1-2 …

glucose tolerance test
low fat diet
low carbohydrate diet
Lishui People's Hospital
 (0.0 away) Contact site
  • 24 Jul, 2021
  • +7 other locations
Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis

A Randomized, Open Label, Phase III Trial to Evaluate Radical Local Treatment versus Palliative Treatment for Breast Cancer Patients with Primary Ipsilateral Humerus or Sternum Oligometastasis

hormone therapy
endocrine therapy
The Central Hospital of Lishui
 (1.1 away) Contact site
  • 25 Jan, 2021
  • +1 other locations
Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer

Open distal pancreatectomy (ODP) has been commonly employed for the treatment of a variety of cancers in body and tail of pancreas. Although many general surgical procedures have been increasingly performed laparoscopically or with laparoscopic assistance, until the current decade, laparoscopic pancreatic surgery had not been performed for its complicated …

lishui municipal Central Hospital
 (1.1 away) Contact site
  • 22 Jan, 2021
  • +3 other locations
To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer

Through the implementation of prospective, multi-center, single-group target value research to verify the safety and effectiveness of the microwave ablation treatment system for the ablation treatment of primary liver cancer.

The Central Hospital of Lishui City
 (1.1 away) Contact site
  • 01 Apr, 2021
  • +12 other locations
Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901)

Variceal hemorrhage is a lethal complication in patients with cirrhosis and portal hypertension. Identification of varices needing treatment in compensated cirrhosis is, therefore, of great therapeutic and prognostic importance. The gold standard for diagnosing gastroesophageal varices and evaluating the risk of variceal hemorrhage is esophagogastroduodenoscopy. According to the Baveno VI …

Zhejiang University Lishui Hospital
 (0.0 away) Contact site
  • 23 Jan, 2021
  • +10 other locations
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)

COVID-19 pandemic with SARS-CoV-2 infection has become a global challenge. Though most cases of COVID-19 are mild, the disease can also be fatal. Patients with liver disease are more susceptible to damage from SARS-CoV-2 infection considering their immunocompromised status. Therefore, early inoculation of SARS-CoV-2 vaccine in patients with liver disease …

The Central Hospital of Lishui City
 (1.1 away) Contact site
  • 20 May, 2021
  • +35 other locations
Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

Variceal hemorrhage is the serious complication in patients with compensated advanced chronic liver disease (cACLD). To evaluate the bleeding risk of varices, esophagogastroduodenoscopy (EGD) should be performed. However, EGD is limited by its invasiveness and uncomfortableness. The Baveno VI criteria recommended that EGD could be spared in patients with liver …

The Central Hospital of Lishui City
 (0.0 away) Contact site
  • 26 Jan, 2021
  • +5 other locations
the Efficacy and Safety of Etanercept Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis

This is a prospective, open-label, one-arm study. The study aims to assess the efficacy and safety of Etanercept therapy which help guide the clinical practice in real-world settings.

Lishui Central Hospital
 (0.0 away) Contact site
  • 22 Jul, 2021
  • +26 other locations